Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,107 | 1,007 | 100.0% |
| Education | $5.24 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,082 | 121 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,702 | 100 | $0 (2024) |
| PFIZER INC. | $1,554 | 112 | $0 (2024) |
| Lilly USA, LLC | $1,250 | 95 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $998.16 | 74 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $978.93 | 80 | $0 (2024) |
| Amgen Inc. | $770.45 | 49 | $0 (2024) |
| GlaxoSmithKline, LLC. | $711.64 | 60 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $691.22 | 29 | $0 (2023) |
| ABBVIE INC. | $545.56 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,210 | 124 | Novo Nordisk Inc ($515.28) |
| 2023 | $2,064 | 118 | Novo Nordisk Inc ($457.51) |
| 2022 | $1,171 | 75 | Lilly USA, LLC ($232.98) |
| 2021 | $1,209 | 84 | AstraZeneca Pharmaceuticals LP ($209.03) |
| 2020 | $806.49 | 52 | AstraZeneca Pharmaceuticals LP ($172.02) |
| 2019 | $2,254 | 167 | AstraZeneca Pharmaceuticals LP ($262.69) |
| 2018 | $2,718 | 200 | Boehringer Ingelheim Pharmaceuticals, Inc. ($368.43) |
| 2017 | $2,680 | 190 | SANOFI-AVENTIS U.S. LLC ($461.28) |
All Payment Transactions
1,010 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Obesity | ||||||
| 12/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.01 | General |
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: PAIN | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.31 | General |
| 11/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.47 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: PAIN | ||||||
| 10/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.31 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 111 | 2,271 | $100,985 | $39,983 |
| 2022 | 5 | 100 | 1,484 | $67,752 | $24,921 |
| 2021 | 4 | 78 | 1,737 | $76,249 | $27,973 |
| 2020 | 14 | 521 | 2,006 | $148,572 | $39,558 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 19 | 2,100 | $90,300 | $37,561 | 41.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 24 | 28 | $3,108 | $1,024 | 32.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 94 | $4,794 | $801.39 | 16.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 28 | 34 | $2,108 | $447.77 | 21.2% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 14 | 15 | $675.00 | $148.96 | 22.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 15 | 1,320 | $56,760 | $22,239 | 39.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 22 | 24 | $2,664 | $875.49 | 32.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 80 | $4,080 | $732.60 | 18.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 12 | 24 | $2,016 | $663.35 | 32.9% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 26 | 36 | $2,232 | $409.98 | 18.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 18 | 1,620 | $69,660 | $26,474 | 38.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 26 | 80 | $4,080 | $737.57 | 18.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 18 | 20 | $2,220 | $714.78 | 32.2% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2021 | 16 | 17 | $289.00 | $46.50 | 16.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 15 | 1,320 | $56,760 | $19,489 | 34.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 119 | 152 | $34,048 | $5,993 | 17.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 157 | 197 | $30,382 | $4,990 | 16.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 38 | 38 | $9,158 | $4,126 | 45.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 14 | 16 | $5,440 | $2,037 | 37.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 39 | 85 | $4,335 | $718.52 | 16.6% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 17 | 19 | $2,109 | $682.06 | 32.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $2,688 | $561.69 | 20.9% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 26 | 27 | $702.00 | $250.75 | 35.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 16 | 16 | $752.00 | $248.64 | 33.1% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 24 | 24 | $1,488 | $214.89 | 14.4% |
About Dr. Brent Hinkle, D.O
Dr. Brent Hinkle, D.O is a Family Medicine healthcare provider based in Claremore, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447434097.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brent Hinkle, D.O has received a total of $15,112 in payments from pharmaceutical and medical device companies, with $2,210 received in 2024. These payments were reported across 1,010 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($15,107).
As a Medicare-enrolled provider, Hinkle has provided services to 810 Medicare beneficiaries, totaling 7,498 services with total Medicare billing of $132,435. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Claremore, OK
- Active Since 12/18/2007
- Last Updated 05/01/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1447434097
Products in Payments
- FARXIGA (Drug) $1,039
- XARELTO (Drug) $784.94
- JARDIANCE (Drug) $743.73
- Ozempic (Drug) $600.63
- TRULICITY (Drug) $564.42
- ELIQUIS (Drug) $521.41
- NURTEC ODT (Drug) $444.51
- CHANTIX (Drug) $399.54
- Victoza (Drug) $387.29
- TRELEGY ELLIPTA (Drug) $382.79
- UBRELVY (Drug) $341.48
- Rybelsus (Drug) $324.85
- Wegovy (Drug) $301.38
- MOUNJARO (Drug) $295.26
- SYMBICORT (Drug) $275.67
- SOLIQUA (Drug) $270.48
- Aimovig (Biological) $259.85
- STIOLTO RESPIMAT (Drug) $239.35
- JANUVIA (Drug) $221.78
- VRAYLAR (Drug) $216.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Claremore
Dr. Seth Nodine, Md, MD
Family Medicine — Payments: $14,679
Dr. Andrew Sperling, D.o, D.O
Family Medicine — Payments: $14,639
Dr. Jeffrey Williams, D.o, D.O
Family Medicine — Payments: $13,050
Christen Greuel, D.o, D.O
Family Medicine — Payments: $6,854
Ashley Bridges
Family Medicine — Payments: $5,694
Dwight Korgan, M.d, M.D
Family Medicine — Payments: $2,358